Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PCAS is a prominent European contract development and manufacturing organization (CDMO) that specializes in the development and production of complex molecules for the life sciences and specialty chemicals markets. The company provides comprehensive services ranging from process R&D and scale-up to the commercial manufacturing of active pharmaceutical ingredients (APIs) and advanced intermediates. PCAS is recognized for its expertise in fine chemistry, including specialized capabilities in high-pressure hydrogenation, low-temperature reactions, and hazardous chemistry. Now operating as a core part of the Seqens group, PCAS maintains several GMP-compliant manufacturing sites across Europe and North America. The company serves a global clientele of major pharmaceutical, biotech, and generic drug companies, supporting both clinical-stage and commercial-market products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PCAS Pharma Synthesis.